Literature DB >> 19475605

Clinical evaluation of highly pathogenic tick-borne flavivirus infection in the mouse model.

Bersabeh Tigabu1, Terry Juelich, Joseph Bertrand, Michael R Holbrook.   

Abstract

The objective of this study was to evaluate the feasibility of using clinical parameters to demonstrate disease progression and differentiate between Omsk hemorrhagic fever virus (OHFV) and Russian spring-summer encephalitis virus (RSSEV) infection in the mouse model. Adult C57BL/6 and balb/c mice were infected with either OHFV or RSSEV by footpad inoculation and their temperature, body weight, clinical signs complete blood count, and blood chemistries were evaluated for up to 15 days post-infection (dpi). Clinical evaluation showed that OHFV infection seriously affects balb/c mice, which had shorter average survival times (ASTs) than other groups. On the contrary, RSSEV infection of C57BL/6 mice was more severe than in balb/c mice. During these studies, the development of fever was not observed and the body weight of OHFV infected balb/c and C57BL/6 mice began to decline sharply starting from day 7 and 8, respectively, which correlated with disease onset. Peak increase of globulin and neutrophils was demonstrated after 9 dpi in OHFV infected mice; however, the lymphocyte number was not affected. Viremia was undetectable in these animals with either virus infection, but virus was found in most organs tested. These results indicate marked differences in the clinical signs, pathology, and immune response of mice infected with either OHFV or RSSEV and further validate the use of this mouse model system to evaluate human disease. Copyright 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2009        PMID: 19475605     DOI: 10.1002/jmv.21524

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  18 in total

1.  Comparative analysis of immune responses to Russian spring-summer encephalitis and Omsk hemorrhagic fever viruses in mouse models.

Authors:  Bersabeh Tigabu; Terry Juelich; Michael R Holbrook
Journal:  Virology       Date:  2010-09-28       Impact factor: 3.616

Review 2.  Broad-spectrum agents for flaviviral infections: dengue, Zika and beyond.

Authors:  Veaceslav Boldescu; Mira A M Behnam; Nikos Vasilakis; Christian D Klein
Journal:  Nat Rev Drug Discov       Date:  2017-05-05       Impact factor: 84.694

3.  Ebola virus epidemic: a deliberate accident?

Authors:  Styliani Loukatou; Paraskevas Fakourelis; Louis Papageorgiou; Vasileios Megalooikonomou; Sophia Kossida; Dimitrios Vlachakis
Journal:  J Mol Biochem       Date:  2014

Review 4.  Tick-Borne Flaviviruses, with a Focus on Powassan Virus.

Authors:  Gábor Kemenesi; Krisztián Bányai
Journal:  Clin Microbiol Rev       Date:  2018-12-12       Impact factor: 26.132

5.  Molecular Mechanisms of Interaction Between Human Immune Cells and Far Eastern Tick-Borne Encephalitis Virus Strains.

Authors:  Natalya V Krylova; Tatiana P Smolina; Galina N Leonova
Journal:  Viral Immunol       Date:  2015-02-19       Impact factor: 2.257

6.  A critical determinant of neurological disease associated with highly pathogenic tick-borne flavivirus in mice.

Authors:  Kentaro Yoshii; Yuji Sunden; Kana Yokozawa; Manabu Igarashi; Hiroaki Kariwa; Michael R Holbrook; Ikuo Takashima
Journal:  J Virol       Date:  2014-02-26       Impact factor: 5.103

7.  Breakdown of the blood-brain barrier during tick-borne encephalitis in mice is not dependent on CD8+ T-cells.

Authors:  Daniel Růžek; Jiří Salát; Sunit K Singh; Jan Kopecký
Journal:  PLoS One       Date:  2011-05-23       Impact factor: 3.240

8.  Chemotactic and inflammatory responses in the liver and brain are associated with pathogenesis of Rift Valley fever virus infection in the mouse.

Authors:  Kimberly K Gray; Melissa N Worthy; Terry L Juelich; Stacy L Agar; Allison Poussard; Dan Ragland; Alexander N Freiberg; Michael R Holbrook
Journal:  PLoS Negl Trop Dis       Date:  2012-02-28

9.  Experimental Assessment of Possible Factors Associated with Tick-Borne Encephalitis Vaccine Failure.

Authors:  Ksenia Tuchynskaya; Viktor Volok; Victoria Illarionova; Egor Okhezin; Alexandra Polienko; Oxana Belova; Anastasia Rogova; Liubov Chernokhaeva; Galina Karganova
Journal:  Microorganisms       Date:  2021-05-29

10.  Release of dengue virus genome induced by a peptide inhibitor.

Authors:  Shee-Mei Lok; Joshua M Costin; Yancey M Hrobowski; Andrew R Hoffmann; Dawne K Rowe; Petra Kukkaro; Heather Holdaway; Paul Chipman; Krystal A Fontaine; Michael R Holbrook; Robert F Garry; Victor Kostyuchenko; William C Wimley; Sharon Isern; Michael G Rossmann; Scott F Michael
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.